US FDA approves Merus' therapy to treat lung, pancreatic cancers

Merus NV

04/12/2024 20:44

Dec 4 (Reuters) - The U.S. Food and Drug Administration
approved Merus NV's  2GH.F  therapy to treat patients with types
of lung and pancreatic cancers on Wednesday.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Krishna
Chandra Eluri)
 ((Sriparna.Roy@thomsonreuters.com;))